Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
Genetic consequences of the latency period in metastasis
EF 2016-17
Résumé
The research objective of this proposal is to use computer simulations of cancer to understand genetic heterogeneity that occurs during metastasis. Cancer is the leading cause of death in Canada with an estimated 78,800 people expected to die in 2016 alone, likely from a relapse or metastasis post-treatment. Multi-region sequencing of tumors has revealed a spectrum of heterogeneity levels, with breast cancer and lung adenocarcinomas having high and low levels of heterogeneity, respectively. It is unclear how this heterogeneity arises, especially in the case of metastatic lesions. However, it is clear that there are tissue-specific parameters that mediate heterogeneity. Latency refers to the time between when a metastasis is first seeded and when it obtains full growth potential. It is hypothesized that immune system activity in different tissues will have an effect on latency. My work aims to make a connection between metastatic latency and heterogeneity by studying tissue-specific parameters like immune system activity under different evolutionary settings. The investigation will proceed in three steps, first considering a genetic model based on the branching process. We then move on to microenvironment models to understand the cellular dynamics of cancer cells interacting with the immune system. Finally, a larger model will be used to provide simulated next-generation sequencing data that can allow for validation from empirical studies. The results of this study can be used to determine which tissues are conductive to high levels of heterogeneity, which will have prognostic value and ultimately inform therapeutic decisions.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
367035
Name
Ahmed Zafarali
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Genetic consequences of the latency period in metastasis
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Circulating Tumor Cells; Clonal Evolution; Computational Oncology; Disseminating Tumor Cells; Evolutionary Cancer Models; Genetic Heterogeneity; Mathematical Modeling; Metastatic Latency; Theoretical Cancer Models
Abstract
The research objective of this proposal is to use computer simulations of cancer to understand genetic heterogeneity that occurs during metastasis. Cancer is the leading cause of death in Canada with an estimated 78,800 people expected to die in 2016 alone, likely from a relapse or metastasis post-treatment. Multi-region sequencing of tumors has revealed a spectrum of heterogeneity levels, with breast cancer and lung adenocarcinomas having high and low levels of heterogeneity, respectively. It is unclear how this heterogeneity arises, especially in the case of metastatic lesions. However, it is clear that there are tissue-specific parameters that mediate heterogeneity. Latency refers to the time between when a metastasis is first seeded and when it obtains full growth potential. It is hypothesized that immune system activity in different tissues will have an effect on latency. My work aims to make a connection between metastatic latency and heterogeneity by studying tissue-specific parameters like immune system activity under different evolutionary settings. The investigation will proceed in three steps, first considering a genetic model based on the branching process. We then move on to microenvironment models to understand the cellular dynamics of cancer cells interacting with the immune system. Finally, a larger model will be used to provide simulated next-generation sequencing data that can allow for validation from empirical studies. The results of this study can be used to determine which tissues are conductive to high levels of heterogeneity, which will have prognostic value and ultimately inform therapeutic decisions.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ahmed, Zafarali
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~